InvestorsHub Logo
Followers 8
Posts 616
Boards Moderated 0
Alias Born 03/17/2011

Re: 10nisman post# 7202

Sunday, 04/28/2024 7:51:28 PM

Sunday, April 28, 2024 7:51:28 PM

Post# of 7406
I was referring to a different post on the biotech values thread which is much closer to what I posted on this thread than the post that you found.


If all the readers of this thread were experienced financial analysts with expertise in biotech, I wouldn’t bother making a single post here. I suspect many of the readers are lurkers with very little biotech expertise and not much investment experience. Those people deserve to get a balanced set of views. If they only read posts from the perma-bulls, they will not get a realistic impression of the risks involved.

Don’t get me started on Alzheimer’s disease. Roy “sicced” Vinman on me when I expressed my views to a new poster questioning four biotech stocks. Essentially, there are dozens of phase 3 trials, all of which have failed. that attacked amyloid Beta or tau plaques. The Aduhelm fiasco was the only time the FDA approved an Alzheimer’s disease treatment. Biogen withdrew it after no healthcare agency would pay the bill nor would doctors prescribe it.

Enjoy the rest of your weekend.
Ian
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RVNC News